The weeklong Cell Therapy stream comprises two back-to-back conference tracks focusing on cell therapy regulation, CMC strategies, analysis, quality control, process development, technology development, scale-up and commercial manufacture of cell and gene-based products, with particular focus on CART and TCR therapies. First stop is Cell Therapy CMC, Quality and Analytics which looks at latest regulations in US and EU followed by in depth sessions on potency assay development, flow cytometry, raw materials, release testing, target product profiles and quality control, followed by two days on Cell Therapy Manufacturing, taking in key topics such as cell therapy manufacturing, commercialization, scale-up, automation, closed systems, technology development, managing external partners and vein-to-vein supply.
2017 CELL THERAPY TRACKS
Cell Therapy CMC, Quality and Analytics
Cell Therapy Bioproduction, Operations and Logistics